Suchergebnisse - "Cook, Gordon"

PubPharm (409)

21

Delayed diagnosis resulting in increased disease burden in multiple myeloma : the legacy of the COVID-19 pandemic

enthalten in: Blood cancer journal | 2023

von Carmichael, J. | Seymour, F. | McIlroy, G. | +9

22

What can we do about patients presenting with myeloma and severe renal failure? Observations from the UK MERIT plasma exchange trial

enthalten in: EJHaem | 2023

von Behrens, J. | Gaskin, G. | Iggo, N. | +7

23

Development and Internal Validation of a Risk Prediction Model to Identify Myeloma Based on Routine Blood Tests : A Case-Control Study

enthalten in: Cancers | 2023

von Smith, L. | Carmichael, J. | Cook, G. | +2

24

Benefits of switching from intravenous to subcutaneous daratumumab : Perspectives from UK healthcare providers

enthalten in: Frontiers in oncology | 2023

von Cook, G. | Ashcroft, J. | Fernandez, M. | +5

25

The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma : A systematic review

enthalten in: Blood cancer journal | 2023

von Mian, H. | McCurdy, A. | Giri, S. | +13

26

The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages : results from ‘Myeloma XI’, a multicentre, open‐label, randomised, phase III trial

enthalten in: British Journal of Haematology | 2023

von Jenner, M. | Pawlyn, C. | Davies, F. | +15

27

Daratumumab, bortezomib and dexamethasone at first relapse for patients with multiple myeloma : A real‐world multicentre UK retrospective analysis

enthalten in: British Journal of Haematology | 2023

von McMillan, A. | Basu, S. | Karunanithi, K. | +22

28

Immune responses to COVID‐19 booster vaccinations in intensively anti‐CD38 antibody treated patients with ultra‐high‐risk multiple myeloma : results from the Myeloma UK ( MUK) nine OPTIMUM trial

enthalten in: British Journal of Haematology | 2023

von Faustini, S. | Hall, A. | Brown, S. | +11

29

Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial) : study protocol for a phase II/III randomised controlled trial

enthalten in: BMJ open | 2022

von Royle, K. | Coulson, A. | Ramasamy, K. | +26

30

Clinical Features Associated with COVID-19 Outcome in MM: First Results from International Myeloma Society COVID-19 Dataset

enthalten in: bioRxiv.org | 2022

von Chari, A. | Samur, M. | Martinez-Lopez, J. | +22